Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.21 AUD | 0.00% | -2.33% | -58.00% |
Business Summary
Sales per Business
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Sleep Related Disorder Devices
100.0
%
| 73 | 100.0 % | 84 | 100.0 % | +15.20% |
Sales per region
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Europe
56.6
%
| 42 | 58.5 % | 47 | 56.6 % | +11.46% |
North America
36.1
%
| 25 | 34.0 % | 30 | 36.1 % | +22.18% |
Asia Pacific
7.3
%
| 5 | 7.5 % | 6 | 7.3 % | +12.76% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 24/20/24 | |
Karen Borg
CEO | Chief Executive Officer | - | 26/20/26 |
Darren Collins
DFI | Director of Finance/CFO | - | 01/23/01 |
David Lewis
CTO | Chief Tech/Sci/R&D Officer | - | 01/20/01 |
Arlene Graham
HRO | Human Resources Officer | - | 01/21/01 |
- | - | ||
Jarred Shein
PRN | Corporate Officer/Principal | - | 01/21/01 |
Mark Harding
SAM | Sales & Marketing | - | 01/19/01 |
Corporate Officer/Principal | - | 01/04/01 | |
Corporate Secretary | - | 01/95/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Hamish Corlett
BRD | Director/Board Member | - | 01/18/01 |
Guy Russo
CHM | Chairman | 65 | 24/20/24 |
Karen Borg
CEO | Chief Executive Officer | - | 26/20/26 |
Michael Gordon
BRD | Director/Board Member | - | 24/20/24 |
Chief Executive Officer | - | 24/20/24 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 216,107,630 | 189,259,553 ( 87.58 %) | 0 | 87.58 % |
Company contact information
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
-58.00% | 18.64M | |
-2.31% | 187B | |
-3.20% | 106B | |
-5.04% | 66.9B | |
+0.20% | 49.45B | |
+17.29% | 48B | |
+4.06% | 40.84B | |
+2.07% | 26.48B | |
+2.36% | 26.25B | |
+12.96% | 24.62B |
- Stock Market
- Equities
- SOM Stock
- Company SomnoMed Limited